• $169.7M
    Market Cap
  • 56.88%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
3.4M
+100.41%
1.7M
N/A
N/A
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
3.4M
+100.41%
1.7M
N/A
0
N/A
0
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-48.3M
+10.20%
-43.8M
-22.64%
-56.6M
+50.15%
-37.7M
+33.85%
Depreciation and Amortization Expense
447,000
-2.61%
459,000
+170.00%
170,000
+93.18%
88,000
+76.00%
Total Operating Expenses
63.0M
+15.75%
54.4M
-34.52%
83.1M
+54.24%
53.8M
+35.24%
Operating Profit
-63.0M
+15.75%
-54.4M
-34.52%
-83.1M
+54.24%
-53.8M
+35.24%
Interest Income
3.4M
+70.94%
2.0M
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
3.4M
+70.94%
2.0M
N/A
0
N/A
0
-100.00%
Total Nonoperating Income and Expense
3.4M
+100.41%
1.7M
-69.76%
5.7M
+199.26%
1.9M
+3,843.75%
Income before Taxes
-63.0M
+15.75%
-54.4M
-34.52%
-83.1M
+54.24%
-53.8M
+35.24%
Income Taxes
0
N/A
N/A
N/A
0
N/A
0
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-59.5M
+12.99%
-52.7M
-31.94%
-77.4M
+48.95%
-52.0M
+30.64%
Net Income from Continuing Operations Applicable to Common
-59.5M
+12.99%
-52.7M
-31.94%
-77.4M
+48.95%
-52.0M
+30.64%
Basic EPS and Net Income
-4.40
-71.20%
-15.28
+506.35%
-2.52
+18.87%
-2.12
-3.20%
Diluted EPS and Net Income
-4.40
-71.20%
-15.28
+506.35%
-2.52
+18.87%
-2.12
-3.20%
Basic Weighted Average Shares
13.5M
+292.10%
3.4M
-88.76%
30.7M
+25.23%
24.5M
+35.01%
Diluted Weighted Average Shares
13.5M
+292.10%
3.4M
-88.76%
30.7M
+25.23%
24.5M
+35.01%
Balance Sheet
Cash and Cash Equivalents
59.0M
-46.69%
110.8M
+300.84%
27.6M
+38.67%
19.9M
-84.01%
Short-Term Investments
N/A
N/A
N/A
N/A
75.3M
-7.28%
81.2M
+253.09%
Cash and Cash Equivalents and Short-Term Investments
59.0M
-46.69%
110.8M
+7.57%
103.0M
+1.77%
101.2M
-31.49%
Total Current Assets
60.8M
-46.16%
113.0M
+5.98%
106.6M
+0.25%
106.4M
-30.82%
Accumulated Depreciation
1.5M
+30.56%
1.1M
+832.50%
120,000
+17.65%
102,000
-23.31%
Property and Plant and Equipment and Net
618,000
-39.71%
1.0M
+664.93%
134,000
-70.42%
453,000
+113.68%
Total Long-Term Assets
273,000
+150.46%
109,000
+34.57%
81,000
-3.57%
84,000
+7.69%
Total Assets
62.1M
-45.94%
114.9M
+6.95%
107.4M
-0.69%
108.2M
-29.76%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Short-Term Debt
6.0M
0.00%
6.0M
N/A
N/A
N/A
N/A
N/A
Total Current Liabilities
5.9M
-43.77%
10.5M
-42.07%
18.2M
+155.15%
7.1M
+14.87%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
12,000
-97.81%
549,000
-15.41%
649,000
+288.62%
167,000
-72.67%
Total Liabilities
5.9M
-46.45%
11.1M
-41.15%
18.8M
+129.25%
8.2M
+20.53%
Retained Earnings
-214.2M
+38.47%
-154.7M
-29.18%
-218.5M
+59.84%
-136.7M
+61.32%
Total Stockholders Equity
56.2M
-45.89%
103.8M
+17.17%
88.6M
-11.36%
100.0M
-32.09%
Total Shares Outstanding
13.7M
+2.45%
13.3M
-60.06%
33.4M
+35.31%
24.7M
+1.00%
Cash Flow
Cash from Operating Activities
-51.8M
+1.39%
-51.1M
-19.73%
-63.7M
+34.46%
-47.4M
+24.69%
Capital Expenditures
46,000
-11.54%
52,000
-76.47%
221,000
-36.13%
346,000
+74.75%
Cash from Investing Activities
-46,000
-100.29%
15.9M
+50.86%
10.5M
+118.19%
-57.8M
+147.44%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
163,000
-99.86%
116.1M
+90.80%
60.9M
+12,822.51%
471,000
-99.64%
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
-1,833.67%
-42.24%
-3,174.90%
N/A
N/A
N/A
N/A
N/A
Return on Assets
-67.24%
+41.92%
-47.38%
-34.00%
-71.78%
+81.14%
-39.63%
N/A
Return on Equity
-74.39%
+35.89%
-54.74%
-33.30%
-82.07%
+95.24%
-42.04%
N/A
Revenue Growth
100.41%
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
10.28
-4.25%
10.73
+82.95%
5.87
-60.71%
14.93
N/A
Cash Ratio
9.97
-5.19%
10.52
+591.92%
1.52
-45.65%
2.80
N/A
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow